DENVER--(BUSINESS WIRE)--Covita Health Partners, a newly launched regulatory and quality consulting firm, is proud to announce its entry into the life sciences industry by offering expert, affordable support to innovators developing medical devices, di...
Results highlight the role of artificial intelligence development in enabling earlier detection of aortic stenosis. The Company announces new Aorta Exam training protocol released on Butterfly ScanLab™BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--But...
dacadoo, a global leader in digital health engagement and health scoring, has annou…
Analyte Founder Fiyyaz Pirani to Continue as CEO and Retain Significant Ownership StakeNEW YORK & HOUSTON--(BUSINESS WIRE)--Brightstar Capital Partners (“Brightstar”), a private equity firm focused on investing in business services, industrials, consu...
Adam Bauer Named CEO of New BusinessNASHVILLE, Tenn.--(BUSINESS WIRE)--#digitalhealth--Caduceus Capital Partners (Caduceus) today announced the formation of Caduceus ADVISORY, a new consulting business that complements the firm’s investment strategy a...
Leaders in clinical, product innovation, and market access will provide guidance for PlaqueIQTM strategyBOSTON & SCCT ANNUAL MEETING, MONTREAL--(BUSINESS WIRE)--#SCCT2025--Elucid, an AI medical technology company focused on providing physicians with a...
SAN JOSE, Calif.--(BUSINESS WIRE)--#AIinHealthcare--Fourth paragraph, first sentence of release dated July 14, 2025 should read: Dr. Ramon Lizardo MD, CEO of Tele911 (instead of Dr. Ramone Lizardo, MD, CEO of Tele911). The updated release reads: VSEE N...
Initiates Prearranged Financial Restructuring Process to Significantly Strengthen Balance Sheet Operations Continue in the Ordinary Course, Including Full Continuity of OneTouch® Glucose Measurement and Management OfferingsMALVERN, Pa.--(BUSINESS WIRE...
WELLSTAR continues to demonstrate strong growth and business momentum through its sustained organic growth and strong acquisition pipeline. The business is ahead of its internal expectations and has updated its guidance to $74 million(1) in total rev...
Investment to accelerate innovations in biopharma development through Corporate Development InitiativeRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, bios...